Access to mechanical thrombectomy for cerebral ischaemia: A population-based study in the North-of-France

Rev Neurol (Paris). 2019 Oct;175(9):519-527. doi: 10.1016/j.neurol.2018.12.010. Epub 2019 Jun 14.

Abstract

Background and purpose: Hospitals admitting acute strokes should offer access to mechanical thrombectomy (MT), but local organisations are still based on facilities available before MT was proven effective. MT rates and outcomes at population levels are needed to adapt organisations. We evaluated rates of MT and outcomes in inhabitants from the North-of-France (NoF) area.

Method: We prospectively evaluated rates of MT and outcomes of patients at 3 months, good outcomes being defined as a modified Rankin scale (mRS) 0 to 2 or like the pre-stroke mRS.

Results: During the study period (2016-2017), 666 patients underwent MT (454, 68.1% associated with intravenous thrombolysis [IVT]). Besides, 1595 other patients received IVT alone. The rate of MT was 81 (95% confidence interval [CI] 72-90) per million inhabitants-year, ranging from 36 to 108 between districts. The rate of IVT was 249 (95% CI 234-264) per million inhabitants-year, ranging from 155 to 268. After 3 months, 279 (41.9%) patients who underwent MT had good outcomes, and 167 (25.1%) had died. Patients living outside the district of Lille where the only MT centre is, were less likely to have good outcomes at 3 months, after adjustment on age, sex, baseline severity, and delay.

Conclusion: The rate of MT is one of the highest reported up to now, even in low-rate districts, but outcomes were significantly worse in patients living outside the district of Lille, and this is not only explained by the delay.

Keywords: Cerebral infarct; Cerebral ischaemia; Population-based study; Stroke; Stroke care; Stroke management; Thrombectomy; Thrombolysis.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brain Ischemia / epidemiology
  • Brain Ischemia / therapy*
  • Cerebral Infarction / epidemiology
  • Cerebral Infarction / therapy
  • Female
  • Fibrinolytic Agents / therapeutic use
  • France / epidemiology
  • Health Services Accessibility / standards
  • Health Services Accessibility / statistics & numerical data*
  • Hospitals, Private / statistics & numerical data
  • Hospitals, Public / statistics & numerical data
  • Humans
  • Male
  • Mechanical Thrombolysis / methods
  • Mechanical Thrombolysis / statistics & numerical data*
  • Middle Aged
  • Stroke / epidemiology
  • Stroke / therapy
  • Thrombectomy / methods
  • Thrombectomy / statistics & numerical data
  • Treatment Outcome

Substances

  • Fibrinolytic Agents